Data Strategist, AI/ML Scientist, Innovator, Digital Health Enthusiast | Big data for better health | Roche, IQVIA, Merck, MIT
Joined November 2013
- Tweets 811
- Following 587
- Followers 150
- Likes 561
19 Photos and videos
19 Nov 2022
An interesting and much-needed development - such a "mechanism-driven" framework for MS is reminiscent of how oncology treatment decisions are more and more based on cancer genomic profiles. This, I believe, is but a stepping stone towards a future with m…lnkd.in/ePxfMM9t
1
28 Oct 2022
I am blessed to have shared these past 3 days of energizing and insightful #medical and #realworldevidence discussions at the #ectrims2022 #medicalcongress with my 3-month old son. Reading #neurology to him is currently the best way to make him fall aslee…lnkd.in/exKgcv5A
Ivan John Clement retweeted
5 May 2021
#AI & #Data - How to Make the Marriage Work
Phase #2: From Engagement to Marriage 💍➡️🗓️🧝🏻♀️🎊🎉❤️
In the spotlight: AI-driven renewed strategies
#CognitiveVirtual - 6 May - Agenda, Speakers, Registration:
➡️ bit.ly/3gDyKpW ⬅️
cc @Roche @davidmeza1
7
13
29 Nov 2020
Indeed - when there’s enough “pressure”, we can find ways to shorten the whole drug/vaccine dev process without sacrificing on quality!
28 Nov 2020
This will go down in history as one of science and medical research's greatest achievements. Perhaps the most impressive.
I put together a preliminary timeline of some key milestones to show how several years of work were compressed into months.
Ivan John Clement retweeted
6 Oct 2020
Are we making meaningful progress on machine learning for EHR data?
New preprint with @DavidRBellamy and Leo Celi tries to answer this question through the lens of benchmarks and the answer is, unfortunately, "probably not"
Paper: arxiv.org/abs/2010.01149
Some highlights 👇
3
73
202
28 Sep 2020
GET€ 20,00! #AliExpressbonus #BonusBuddies
Your bonus is waiting to be activated.
a.aliexpress.com/_mME6SsT
Ivan John Clement retweeted
15 Sep 2020
I'm excited to announce... we're unveiling a landmark collaboration, 𝑇ℎ𝑒 𝑃𝑙𝑎𝑦𝑏𝑜𝑜𝑘, the essential how-to guide to develop and deploy digital clinical measures across clinical care, research, and public health.
Launching tomorrow! Sneak peek: playbook.dimesociety.org
1
30
99
Ivan John Clement retweeted
21 Jul 2020
Take the competitive advantage of applying machine learning to small data sets. Paired with deep human knowledge, could be a game changer!
hbr.org/amp/2020/02/small-da…
#datascience #machinelearning #ArtificialIntelligence #data #ai #bigdata #deeplearning #analytics #statistics
7
4
21 Jul 2020
Good to see the developments in the #digital #endpoints space for #pharma! Give it a few more years and we won’t be able to imagine a world where clinical trials won’t have such!
21 Jul 2020
30 pharma companies have submitted a digital endpoint to regulators to support a primary, secondary, or label claim.
This tech isn't "exploratory" anymore. It's core to drug development.
Welcome to the world of decentralized clinical trials. 🚀
dimesociety.org/index.php/kn…
1
Ivan John Clement retweeted
30 Apr 2020
Humankind has never had a more urgent task than creating broad immunity for coronavirus. It’s going to require a global cooperative effort like the world has never seen. But I know we’ll get it done. There’s simply no alternative. gatesnot.es/3d06cC2
14,365
5,705
24,992
26 Jul 2019
“In broad terms, an agile organization is one that combines a stable backbone of core processes and capabilities with a high degree of flexibility for rapid response to change.”
And data analytics can help in the agile transformat…lnkd.in/fp-_7cF lnkd.in/f-p4K_h
20 Jun 2019
“Alphabet’s Google will bring its artificial-intelligence and cloud-computing capabilities to a new partnership with pharma giant Sanofi.
The project is aimed at accelerating the discovery of new medicines, increasing the understa…lnkd.in/fSe3GZM lnkd.in/faiCPFa
18 Jun 2019
“How do [different clinical] specialties work together with primary care around the A1C and not only slow the progression of diabetes, but also the complications and comorbidities that are exacerbated by their diabetes? ...that is…lnkd.in/fWzZ_fv lnkd.in/f7R_sTS
14 Jun 2019
Atomwise incorporates protein structure data in its analysis to not only identify promising compounds from known libraries, but also to make predictions for virtually synthesized novel molecules that have never physically existed.…lnkd.in/fM2w-XT lnkd.in/fQVMmwN
14 Jun 2019
10 Jun 2019
Sounds a lot like OHDSI (i.e. in the observational/real-world evidence space), but for pharma drug discovery!
“MELLODDY (Machine Learning Ledger Orchestration for Drug Discovery) project...aims, for the first time, to use machine…lnkd.in/fwiXbbF lnkd.in/fhTKyGR
6 Jun 2019
Cool study with deep multi-omics data enabling the investigation of early molecular signs of diabetes progression at an individual level! lnkd.in/frE_-nW
4 Jun 2019
Wow exciting stuff for an MNC pharma to open a global HQ in China!
“In his opening speech, Group President Michael Goettler stressed the significance of this historic moment...’Basing our global headquarters in China will enable u…lnkd.in/fS3wbQM lnkd.in/fbSjdJV
26 Feb 2019
When asked to identify the greatest challenge facing their #translationalmedicine (TM) groups, 76% of respondents pointed to the difficulty in defining clear metrics to measure long-term success, given the additive impact of TM activities on the overall R…lnkd.in/fHqxvr8
26 Feb 2019
When asked to identify the greatest challenge facing their #translationalmedicine (TM) groups, 76% of respondents pointed to the difficulty in defining clear metrics to measure long-term success, given the additive impact of TM act…lnkd.in/f6YgdyC lnkd.in/frnufJD